PUMA BIOTECHNOLOGY, INC. Basic Shares Outstanding (Weighted Average)
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Basic Shares Outstanding (Weighted Average) of 50.94 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- PUMA BIOTECHNOLOGY, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 50.94M shares, a 2.49% increase year-over-year.
- PUMA BIOTECHNOLOGY, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 50.85M shares, a 2.52% increase year-over-year.
- PUMA BIOTECHNOLOGY, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 50.40M shares, a 2.65% increase year-over-year.
- PUMA BIOTECHNOLOGY, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 50.34M shares, a 2.72% increase year-over-year.
- PUMA BIOTECHNOLOGY, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 50.01M shares, a 2.80% increase from fiscal 2024.
- PUMA BIOTECHNOLOGY, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 48.65M shares, a 3.21% increase from fiscal 2023.
- PUMA BIOTECHNOLOGY, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 47.13M shares, a 5.51% increase from fiscal 2022.
- PUMA BIOTECHNOLOGY, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 44.67M shares, a 9.93% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 50.94M shares 10-Q · filed 2026-08-06 | 50.89M shares 10-Q · filed 2026-08-06 | 50.73M shares derived: average of 3 quarters · filed 2026-08-06 | 50.63M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 50.85M shares 10-Q · filed 2026-05-07 | 50.62M shares derived: average of 2 quarters · filed 2026-05-07 | 50.53M shares derived: average of 3 quarters · filed 2026-05-07 | 50.32M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 50.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 50.37M shares derived: average of 2 quarters · filed 2026-02-26 | 50.15M shares derived: average of 3 quarters · filed 2026-08-06 | 50.01M shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 50.34M shares 10-Q · filed 2025-11-06 | 50.02M shares derived: average of 2 quarters · filed 2026-08-06 | 49.88M shares 10-Q · filed 2025-11-06 | 49.68M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 49.70M shares 10-Q · filed 2026-08-06 | 49.65M shares 10-Q · filed 2026-08-06 | 49.46M shares derived: average of 3 quarters · filed 2026-08-06 | 49.35M shares derived: average of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 49.60M shares 10-Q · filed 2026-05-07 | 49.35M shares derived: average of 2 quarters · filed 2026-05-07 | 49.23M shares derived: average of 3 quarters · filed 2026-05-07 | 49.00M shares derived: average of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | 49.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 49.05M shares derived: average of 2 quarters · filed 2026-02-26 | 48.80M shares derived: average of 3 quarters · filed 2026-02-26 | 48.65M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 49.01M shares 10-Q · filed 2025-11-06 | 48.65M shares derived: average of 2 quarters · filed 2025-11-06 | 48.50M shares 10-Q · filed 2025-11-06 | 48.27M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | 48.29M shares 10-Q · filed 2025-08-07 | 48.24M shares 10-Q · filed 2025-08-07 | 48.03M shares derived: average of 3 quarters · filed 2026-02-26 | 47.90M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | 48.19M shares 10-Q · filed 2025-05-08 | 47.90M shares derived: average of 2 quarters · filed 2026-02-26 | 47.77M shares derived: average of 3 quarters · filed 2026-02-26 | 47.52M shares derived: average of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | 47.61M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 47.56M shares derived: average of 2 quarters · filed 2026-02-26 | 47.30M shares derived: average of 3 quarters · filed 2026-02-26 | 47.13M shares 10-K · filed 2026-02-26 |
| 2023-09-30 | 47.52M shares 10-Q · filed 2024-11-07 | 47.14M shares derived: average of 2 quarters · filed 2024-11-07 | 46.98M shares 10-Q · filed 2024-11-07 | 46.69M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | 46.76M shares 10-Q · filed 2024-08-01 | 46.70M shares 10-Q · filed 2024-08-01 | 46.41M shares derived: average of 3 quarters · filed 2025-02-27 | 46.20M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | 46.64M shares 10-Q · filed 2024-05-02 | 46.23M shares derived: average of 2 quarters · filed 2025-02-27 | 46.01M shares derived: average of 3 quarters · filed 2025-02-27 | 45.77M shares derived: average of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | 45.83M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 45.70M shares derived: average of 2 quarters · filed 2025-02-27 | 45.48M shares derived: average of 3 quarters · filed 2025-02-27 | 44.67M shares 10-K · filed 2025-02-27 |
| 2022-09-30 | 45.57M shares 10-Q · filed 2023-11-02 | 45.31M shares derived: average of 2 quarters · filed 2023-11-02 | 44.29M shares 10-Q · filed 2023-11-02 | 43.46M shares derived: average of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | 45.06M shares 10-Q · filed 2023-08-03 | 43.64M shares 10-Q · filed 2023-08-03 | 42.75M shares derived: average of 3 quarters · filed 2024-02-29 | 42.27M shares derived: average of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | 42.21M shares 10-Q · filed 2023-05-04 | 41.60M shares derived: average of 2 quarters · filed 2024-02-29 | 41.34M shares derived: average of 3 quarters · filed 2024-02-29 | 41.12M shares derived: average of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | 41.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 40.90M shares derived: average of 2 quarters · filed 2024-02-29 | 40.76M shares derived: average of 3 quarters · filed 2024-02-29 | 40.64M shares 10-K · filed 2024-02-29 |
| 2021-09-30 | 40.81M shares 10-Q · filed 2022-11-03 | 40.65M shares derived: average of 2 quarters · filed 2022-11-03 | 40.52M shares 10-Q · filed 2022-11-03 | 40.36M shares derived: average of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | 40.48M shares 10-Q · filed 2022-08-04 | 40.37M shares 10-Q · filed 2022-08-04 | 40.21M shares derived: average of 3 quarters · filed 2022-08-04 | 40.08M shares derived: average of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | 40.26M shares 10-Q · filed 2022-05-05 | 40.07M shares derived: average of 2 quarters · filed 2022-05-05 | 39.95M shares derived: average of 3 quarters · filed 2022-05-05 | 39.82M shares derived: average of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | 39.88M shares 10-K · filed 2021-03-01 | 39.79M shares derived: average of 2 quarters · filed 2021-11-04 | 39.67M shares derived: average of 3 quarters · filed 2021-11-04 | 39.58M shares 10-K · filed 2023-03-02 |
| 2020-09-30 | 39.70M shares 10-Q · filed 2021-11-04 | 39.56M shares derived: average of 2 quarters · filed 2021-11-04 | 39.47M shares 10-Q · filed 2021-11-04 | |
| 2020-06-30 | 39.43M shares 10-Q · filed 2021-08-05 | 39.36M shares 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | 39.29M shares 10-Q · filed 2021-05-06 | |||
| 2019-09-30 | 38.89M shares 10-Q · filed 2020-11-05 | 38.77M shares derived: average of 2 quarters · filed 2020-11-05 | 38.68M shares 10-Q · filed 2020-11-05 | |
| 2019-06-30 | 38.65M shares 10-Q · filed 2020-08-06 | 38.57M shares 10-Q · filed 2020-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |